Lama Daila schreef op 17 april 2020 16:56:
[...]
Met de hulp van Paté iets meer bevestiging gevonden dat de link van deze 2 patenten aan GLPG3312 en GLPG3970 zou kunnen kloppen. En dus ook de stelling TOL1=SIK1, TOL2=SIK2 en TOL3=SIK3.
galapagos.gcs-web.com/static-files/2a...GLPG3312 product candidate: We have a pending patent application under the PCT, as well as patent applications pending in Taiwan and other foreign countries claiming GLPG3312 compositions of matter and methods of treatment using GLPG3312. Patents, if any, that issue based on this pending patent application are estimated to expire in 2038, not including any potential extensions for the marketed product that may be available via supplementary protection certificates or patent term extensions.
GLPG3970 product candidate: We have a pending patent application under the PCT, as well as patent applications pending in Taiwan and other foreign countries claiming GLPG3970 compositions of matter and methods of treatment using GLPG3970. Patents, if any, that issue based on this pending patent application are estimated to expire in 2039, not including any potential extensions for the marketed product that may be available via supplementary protection certificates or patent term extensions.
GLPG3312: Filing date WO 2019/105886 = 26.11.2018 -> + 20j = 2038
GLPG3970: Filing date WO 2019/238424 = 29.05.2019 -> + 20j = 2039
en.wikipedia.org/wiki/Term_of_patentThe term of a patent is the maximum time during which it can be maintained in force. It is usually expressed in a number of years either starting from the filing date of the patent application or from the date of grant of the patent.
Dat zou dus kunnen kloppen.
Dat zou dan ook betekenen dat we voor GLPG4399 de filing van het patent mogen verwachten in 2020:
GLPG4399 product candidate: We have one pending UK patent application claiming GLPG4399 compositions of matter and methods of treatment using GLPG4399. Patents, if any, that issue based on this pending patent application are estimated to expire in 2040, not including any potential extensions for the marketed product that may be available via supplementary protection certificates or patent term extensions.